No significant association between PIK3CA mutation and survival of esophageal squamous cell carcinoma: A meta-analysis

Abstract

The prognostic value of phosphatidylinositol-4, 5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA) in patients with esophageal squamous cell carcinoma (ESCC) is controversial. We aimed to investigate the prognostic significance of PIK3CA mutation in patients with ESCC. EMBASE, PubMed, and Web of Science databases were systematically searched from inception through Oct. 3, 2016. The hazard ratios (HRs) and 95% confidence intervals (CI) were calculated using a random effects model for overall survival (OS) and disease-free survival (DFS). Seven studies enrolling 1505 patients were eligible for inclusion of the current meta-analysis. Results revealed that PIK3CA mutation was not significantly associated with OS (HR: 0.90, 95% CI: 0.63–1.30, P=0.591), with a significant heterogeneity (I²=65.7%, P=0.012). Additionally, subgroup analyses were further conducted according to various variables, such as types of specimen, the sample size, technique and statistical methodology. All results suggested that no significant relationship was found between PIK3CA mutation and OS in patients with ESCC. For DFS, there was no significant association between PIK3CA mutation and DFS in patients with ESCC (HR: 1.00, 95% CI=0.47–2.11, P=0.993, I²=73.7%). Publication bias was not present and the results of sensitivity analysis were very stable in the current meta-analysis. Our findings suggest that PIK3CA mutation has no significant effects on OS and DFS in ESCC patients. More well-designed prospective studies with better methodology for PIK3CA assessment are required to clarify the prognostic significance of PIK3CA mutation in ESCC patients.

Keywords

phosphatidylinositol-4 / 5-bisphosphate 3-kinase / catalytic subunit alpha / esophageal squamous cell carcinoma / prognosis / meta-analysis

References

[1] FitzmauriceC, DickerD, PainA, et al. . The Global Burden of Cancer 2013. JAMA Oncol, 2015, 1(4): 505-527 PMID: 26181261

[2] DaviesAR, PillaiA, SinhaP, et al. . Factors associated with early recurrence and death after esophagectomy for cancer. J Surg Oncol, 2014, 109(5): 459-464 PMID: 24301461

[3] LiC, YanY, JiW, et al. . OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma. PLoS One, 2012, 7(11): e496934

[4] RadA E, DizghandiS, AbbaszadeganMR, et al. . SOX1 is correlated to stemness state regulator SALL4 through progression and invasiveness of esophageal squamous cell carcinoma. Gene, 2016, 594(2): 171-175 PMID: 27576349

[5] TominagaK, DoyamaH, NakanishiH, et al. . Importance of colonoscopy in patients undergoing endoscopic resection for superficial esophageal squamous cell carcinoma. Ann Gastroenterol, 2016, 29(3): 318-324 PMID: 27366032 PMCID: 4923817

[6] TerashimaJ, SampeiS, IidzukaM, et al. . VEGF expression is regulated by HIF-1alpha and ARNT in 3D KYSE-70, esophageal cancer cell spheroids. Cell Biol Int, 2016, 40(11): 1187-1194 PMID: 27542820

[7] WangWJ, WuMJ, ChangJ, et al. . Role of human epidermal growth factor receptor 2 as a prognostic factor for survival in esophageal carcinoma: evidence from 2872 subjects. Minerva Med, 2016, 107(5): 328-341 PMID: 27309036

[8] WinnayJN, SolheimMH, DiriceE, et al. . PI3-kinase mutation linked to insulin and growth factor resistance in vivo. J Clin Invest, 2016, 126(4): 1401-1412 PMID: 26974159 PMCID: 4811129

[9] O’brienC, WallinJJ, SampathD, et al. . Predictive biomarkers of sensitivity to the phosphatidylinositol 3’ kinase inhibitor GDC-0941 in breast cancer preclinical models. Clin Cancer Res, 2010, 16(14): 3670-3683 PMID: 20453058

[10] GermanS, AslamHM, SaleemS, et al. . Carcinogenesis of PIK3CA. Hered Cancer Clin Pract, 2013, 11(1): 5 PMID: 23768168 PMCID: 3702456

[11] AgarwalR, CareyM, HennessyB, et al. . PI3K pathway-directed therapeutic strategies in cancer. Curr Opin Investig Drugs, 2010, 11(6): 615-628 PMID: 20496256

[12] SamuelsY, DiazL J, Schmidt-KittlerO, et al. . Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell, 2005, 7(6): 561-573 PMID: 15950905

[13] TanakaH, YoshidaM, TanimuraH, et al. . The selective class I PI3K inhibitor CH5132799 targets human cancers harboring oncogenic PIK3CA mutations. Clin Cancer Res, 2011, 17(10): 3272-3281 PMID: 21558396

[14] ZhanZY, ZhongLX, FengM, et al. . Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma. Int J Clin Exp Pathol, 2015, 8(5): 5080-5088 PMID: 26191202 PMCID: 4503074

[15] UddinS, HussainAR, KhanOS, et al. . Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis. Tumor Biology, 2014, 35(2): 871-879 PMID: 24014051

[16] PfistererK, FusiA, KlinghammerKF, et al. . PI3K/PTEN/ AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel. Head Neck, 2015, 37(4): 471-478 PMID: 24421178

[17] SongB, CuiHY, LiYP, et al. . Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China. Oncotarget, 2016, 7(3): 3599-3613 PMID: 26528858

[18] KimHS, LeeSE, BaeYS, et al. . PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Oncotarget, 2016, 7(21): 30691-30701 PMID: 27095573 PMCID: 5058710

[19] AkagiI, MiyashitaM, MakinoH, et al. . Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma. Int J Oncol, 2009, 34(3): 767-775 PMID: 19212681

[20] WadaS, NoguchiT, TakenoS, et al. . PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma. Ann Surg Oncol, 2006, 13(7): 961-966 PMID: 16788758

[21] KnoblochK, YoonU, VogtPM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg, 2011, 39(2): 91-92 PMID: 21145753

[22] StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605 PMID: 20652370

[23] EggerM D, SmithG, SchneiderM, et al. . Bias in meta-analysis detected by a simple, graphical test. BMJ, 1997, 315(7109): 629-634 PMID: 9310563 PMCID: 2127453

[24] ShigakiH, BabaY, WatanabeM, et al. . PIK3CA mutation is associated with a favorable prognosis among patients with curatively resected esophageal squamous cell carcinoma. Clin Cancer Res, 2013, 19(9): 2451-2459 PMID: 23532889

[25] HouJ, JiangD, ZhangJ, et al. . Frequency, characterization, and prognostic analysis of PIK3CA gene mutations in Chinese esophageal squamous cell carcinoma. Hum Pathol, 2014, 45(2): 352-358 PMID: 24360885

[26] WangL, ShanL, ZhangSK, et al. . PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma. Plos One, 2014, 9(7): 103021

[27] ZhengST, YangCC, LuM, et al. . PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma. Hum Pathol, 2016, 53: 121-129 PMID: 27001433

[28] WangK, JohnsonA, AliSM, et al. . Comprehensive genomic profiling of advanced esophageal squamous cell carcinomas and esophageal adenocarcinomas reveals similarities and differences. Oncology, 2015, 20(10): 1132-1139

[29] ZhengHL, WangY, TangCN, et al. . TP53, PIK3CA, FBXW7 and KRAS mutations in esophageal cancer identified by targeted sequencing. Cancer Genomics Proteomics, 2016, 13(3): 231-238 PMID: 27107065

[30] CantleyLC. The phosphoinositide 3-kinase pathway. Science, 2002, 296(5573): 1655-1657 PMID: 12040186

[31] PaleariL, PuntoniM, ClavarezzaM, et al. . PIK3CA mutation, aspirin use after diagnosis and survival of colorectal cancer. A systematic review and meta-analysis of epidemiological studies. Clin Oncol (R Coll Radiol), 2016, 28(5): 317-326

[32] ZhouY, WangC, ZhuH, et al. . Diagnostic accuracy of PIK3CA mutation detection by circulating free DNA in breast cancer: A meta-analysis of diagnostic test accuracy. PLoS One, 2016, 11(6): 0158143

[33] ChenJY, ChengYN, HanL, et al. . Predictive value of K-ras and PIK3CA in non-small cell lung cancer patients treated with EGFR-TKIs: a systemic review and meta-analysis. Cancer Biol Med, 2015, 12(2): 126-139 PMID: 26175928 PMCID: 4493374

[34] IoannidisJP. How to make more published research true. PLoS Med, 2014, 11(10): 1001747